956 related articles for article (PubMed ID: 32573903)
1. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
4. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.
Wu ZH; Tang Y; Cheng Q
Acta Diabetol; 2021 Feb; 58(2):139-144. PubMed ID: 32583078
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
6. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of co-morbidities and its association with mortality in Indian patients with COVID-19: A meta-analysis.
Jindal R; Gupta M; Khan FR; Chaudhry G
Indian J Anaesth; 2022 Jun; 66(6):399-418. PubMed ID: 35903589
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
9. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.
Khan MMA; Khan MN; Mustagir MG; Rana J; Islam MS; Kabir MI
J Glob Health; 2020 Dec; 10(2):020503. PubMed ID: 33110586
[TBL] [Abstract][Full Text] [Related]
10. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.
Jayaswal SK; Singh S; Malik PS; Venigalla SK; Gupta P; Samaga SN; Hota RN; Bhatia SS; Gupta I
Diabetes Metab Syndr; 2021; 15(5):102248. PubMed ID: 34412000
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, obesity and COVID-19: A complex interplay.
Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
[TBL] [Abstract][Full Text] [Related]
12. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
13. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.
Schlesinger S; Neuenschwander M; Lang A; Pafili K; Kuss O; Herder C; Roden M
Diabetologia; 2021 Jul; 64(7):1480-1491. PubMed ID: 33907860
[TBL] [Abstract][Full Text] [Related]
14. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis.
Luo L; Fu M; Li Y; Hu S; Luo J; Chen Z; Yu J; Li W; Dong R; Yang Y; Tu L; Xu X
Clin Cardiol; 2020 Dec; 43(12):1478-1493. PubMed ID: 33026120
[TBL] [Abstract][Full Text] [Related]
15. Features of severe COVID-19: A systematic review and meta-analysis.
Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
[TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
[TBL] [Abstract][Full Text] [Related]
17. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.
Ssentongo P; Ssentongo AE; Heilbrunn ES; Ba DM; Chinchilli VM
PLoS One; 2020; 15(8):e0238215. PubMed ID: 32845926
[TBL] [Abstract][Full Text] [Related]
18. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
19. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA.
;
Nephrol Dial Transplant; 2021 Jan; 36(1):87-94. PubMed ID: 33340043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
